Scot E. Purdon

4.7k total citations
86 papers, 3.3k citations indexed

About

Scot E. Purdon is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Scot E. Purdon has authored 86 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Psychiatry and Mental health, 26 papers in Cognitive Neuroscience and 12 papers in Clinical Psychology. Recurrent topics in Scot E. Purdon's work include Schizophrenia research and treatment (38 papers), Functional Brain Connectivity Studies (20 papers) and Bipolar Disorder and Treatment (12 papers). Scot E. Purdon is often cited by papers focused on Schizophrenia research and treatment (38 papers), Functional Brain Connectivity Studies (20 papers) and Bipolar Disorder and Treatment (12 papers). Scot E. Purdon collaborates with scholars based in Canada, United States and Spain. Scot E. Purdon's co-authors include Neil D. Woodward, Herbert Y. Meltzer, David H. Zald, Alain Labelle, Philip G. Tibbo, Kenneth A. Wallston, Ashok Malla, Eduard Vieta, Dawn K. Wilson and Kamilla Woznica Miskowiak and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Magnetic Resonance in Medicine.

In The Last Decade

Scot E. Purdon

86 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scot E. Purdon Canada 30 2.1k 940 508 433 417 86 3.3k
Jean‐Pierre Olié France 31 1.5k 0.7× 731 0.8× 796 1.6× 350 0.8× 272 0.7× 109 2.8k
Nicholas C. Stefanis Greece 26 1.7k 0.8× 818 0.9× 1.1k 2.1× 333 0.8× 426 1.0× 59 3.2k
Theo C. Manschreck United States 33 2.2k 1.0× 1.3k 1.3× 779 1.5× 396 0.9× 673 1.6× 114 3.5k
Haruo Kashima Japan 31 1.2k 0.6× 735 0.8× 429 0.8× 251 0.6× 229 0.5× 126 2.7k
S. Kristian Hill United States 27 1.9k 0.9× 1.2k 1.2× 411 0.8× 188 0.4× 286 0.7× 81 2.9k
Gagan Fervaha Canada 29 2.0k 0.9× 701 0.7× 550 1.1× 272 0.6× 573 1.4× 96 2.8k
Rohan Ganguli United States 35 2.0k 0.9× 588 0.6× 522 1.0× 492 1.1× 236 0.6× 118 4.0k
M Casacchia Italy 36 2.0k 0.9× 1.1k 1.2× 1.2k 2.4× 375 0.9× 524 1.3× 183 4.0k
Roberto Rodríguez–Jiménez Spain 34 1.4k 0.7× 698 0.7× 854 1.7× 600 1.4× 196 0.5× 158 3.7k
Marc‐André Roy Canada 39 2.3k 1.1× 776 0.8× 1.2k 2.4× 234 0.5× 552 1.3× 174 4.4k

Countries citing papers authored by Scot E. Purdon

Since Specialization
Citations

This map shows the geographic impact of Scot E. Purdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scot E. Purdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scot E. Purdon more than expected).

Fields of papers citing papers by Scot E. Purdon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scot E. Purdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scot E. Purdon. The network helps show where Scot E. Purdon may publish in the future.

Co-authorship network of co-authors of Scot E. Purdon

This figure shows the co-authorship network connecting the top 25 collaborators of Scot E. Purdon. A scholar is included among the top collaborators of Scot E. Purdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scot E. Purdon. Scot E. Purdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenshaw, Andrew J., et al.. (2021). Web-Based Eye Movement Desensitization and Reprocessing for Adults With Suicidal Ideation: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 10(11). e30711–e30711. 3 indexed citations
2.
Nealis, Logan J., et al.. (2021). Identification of psychiatric inpatient recovery trajectories using routine outcome monitoring with emerging adults. Psychiatry Research. 302. 114000–114000. 2 indexed citations
3.
4.
Tourjman, Smadar Valérie, Robert‐Paul Juster, Scot E. Purdon, et al.. (2018). The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression. International Journal of Psychiatry in Clinical Practice. 23(1). 49–56. 14 indexed citations
5.
Potvin, Stéphane, Geneviève Charbonneau, Robert‐Paul Juster, Scot E. Purdon, & Smadar Valérie Tourjman. (2016). Self-evaluation and objective assessment of cognition in major depression and attention deficit disorder: Implications for clinical practice. Comprehensive Psychiatry. 70. 53–64. 41 indexed citations
6.
Fujiwara, Esther, et al.. (2015). Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV). Journal of Clinical and Experimental Neuropsychology. 37(7). 733–750. 11 indexed citations
7.
Tibbo, Philip G., et al.. (2012). 3‐T proton magnetic spectroscopy in unmedicated first episode psychosis: A focus on creatine. Magnetic Resonance in Medicine. 69(3). 613–620. 24 indexed citations
8.
Purdon, Scot E., et al.. (2011). MMPI-2 Restructured Form Over-Reporting Scales in First-Episode Psychosis. The Clinical Neuropsychologist. 25(5). 829–842. 4 indexed citations
9.
10.
Purdon, Scot E., et al.. (2011). Procedural learning in first episode schizophrenia investigated with functional magnetic resonance imaging.. Neuropsychology. 25(2). 147–158. 15 indexed citations
11.
Rojo, Emilio, Óscar Pino, Georgina Guilera, et al.. (2009). Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S). Schizophrenia Research. 116(2-3). 243–251. 57 indexed citations
12.
Purdon, Scot E., et al.. (2008). Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia. Schizophrenia Research. 99(1-3). 218–224. 59 indexed citations
13.
Pino, Óscar, Georgina Guilera, Emilio Rojo, et al.. (2007). Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia. Schizophrenia Research. 99(1-3). 139–148. 82 indexed citations
14.
Woodward, Neil D., et al.. (2006). Procedural learning in schizophrenia investigated with functional magnetic resonance imaging. Schizophrenia Research. 88(1-3). 198–207. 40 indexed citations
15.
Keefe, Richard S.E., Carrie A. Young, Stephanie Rock, et al.. (2005). One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophrenia Research. 81(1). 1–15. 116 indexed citations
16.
Woodward, Neil D., Scot E. Purdon, Herbert Y. Meltzer, & David H. Zald. (2005). A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. The International Journal of Neuropsychopharmacology. 8(3). 457–472. 466 indexed citations
17.
Purdon, Scot E., Neil D. Woodward, Stacy Lindborg, & Émmanuel Stip. (2003). Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology. 169(3-4). 390–397. 62 indexed citations
18.
Purdon, Scot E.. (2002). Antidepressant Effects of Repetitive Transcranial Magnetic Stimulation in the Elderly: Correlation Between Effect Size and Coil-Cortex Distance. Archives of General Psychiatry. 59(6). 573–573. 22 indexed citations
19.
Purdon, Scot E., Alain Labelle, & L. Boulay. (2001). Neuropsychological change in schizophrenia after 6 weeks of clozapine. Schizophrenia Research. 48(1). 57–67. 40 indexed citations
20.
Purdon, Scot E.. (2000). Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol. Archives of General Psychiatry. 57(3). 249–249. 398 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Olié Breakdown of academic impact, for papers by Nicholas C. Stefanis Breakdown of academic impact, for papers by Theo C. Manschreck Breakdown of academic impact, for papers by Haruo Kashima Breakdown of academic impact, for papers by S. Kristian Hill Breakdown of academic impact, for papers by Gagan Fervaha Breakdown of academic impact, for papers by Rohan Ganguli Breakdown of academic impact, for papers by M Casacchia Breakdown of academic impact, for papers by Roberto Rodríguez–Jiménez Breakdown of academic impact, for papers by Marc‐André Roy
Rankless by CCL
2026